Abuse and Misuse of Pregabalin and Gabapentin

@article{Evoy2017AbuseAM,
  title={Abuse and Misuse of Pregabalin and Gabapentin},
  author={Kirk E. Evoy and Megan D. Morrison and Stephen R Saklad},
  journal={Drugs},
  year={2017},
  volume={77},
  pages={403-426}
}
BackgroundGabapentinoid (pregabalin and gabapentin) abuse is increasingly being reported.ObjectiveTo assess the extent of gabapentinoid abuse, characteristics of typical abusers, patterns of abuse, and potential harms in order to bring this trend to providers’ attention.MethodsA systematic review of MEDLINE, Cochrane Library, ClinicalTrials.gov, and US FDA data, indexed through 28 July 2016, utilizing the following searches: pregabalin OR gabapentin OR gabapentinoid AND one of the following… Expand
Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review Update
TLDR
Evidence suggests that gabapentinoid misuse/abuse represents a growing trend that is causing significant patient harm, and prescribers should exercise appropriate caution with use in high-risk populations and monitor for signs of misuse or abuse. Expand
Abuse liability of gabapentin in the Saudi population after the pregabalin restriction: A cross-sectional study
TLDR
The findings of this study suggest a potential diversion from Pregabalin to Gabapentin misuse, and Regulations and periodic reviews of the psychoactive prescription medications available in the community pharmacies are essential. Expand
How addictive are gabapentin and pregabalin? A systematic review
TLDR
The addiction risks of gabapentin and pregabalin are compared with those of traditional psychoactive substances and recommend that in patients with a history of SUD, gabAPentinoids should be avoided or if indispensable, administered with caution by using a strict therapeutic and prescription monitoring. Expand
[On the risk of dependence on gabapentinoids].
TLDR
It is thought that in patients with current or past substance use disorders, the treatment with gabapentinoids should be avoided or if indispensable, these drugs should be administered exclusively over a limited time span with caution by using a therapeutic and prescription monitoring. Expand
Pregabalin Misuse and Abuse: A Scoping Review of Extant Literature
Prescribing of pregabalin is increasing worldwide with public health concerns centering on misuse and abuse of prescribed and diverted pregabalin. To describe and map what is known about misuse andExpand
Gabapentinoid Use Disorder: Update for Clinicians
Citation: Pergolizzi., et al. “Gabapentinoid Use Disorder: Update for Clinicians”. EC Anaesthesia 4.8 (2018): 303-317. Abstract Gabapentinoids (gabapentin and pregabalin) are versatile drugs,Expand
Management of overdoses of loperamide, gabapentin, and modafinil: a literature review
TLDR
This review provides a repository of standard and emerging treatment modalities for loperamide, gabapentin and modafinil for the emergency medicine team and should be on the radar of healthcare providers. Expand
Reports of gabapentin and pregabalin abuse, misuse, dependence, or overdose: An analysis of the Food And Drug Administration Adverse Events Reporting System (FAERS).
TLDR
Though not traditionally thought of as drugs of abuse, over 600 cases of gabapentinoid abuse were reported in the time frame analyzed, prompting the need for further study and regulatory investigation. Expand
Gabapentinoid Abuse in France: Evidence on Health Consequences and New Points of Vigilance
TLDR
Addictovigilance data helped to make visible the gabapentinoid-abuse related health harms and to confirm the intrinsic abuse potential of pregabalin, which has become the first drug mentioned in forged prescriptions in 2019. Expand
Gabapentin and Pregabalin for the Treatment of Anxiety Disorders
TLDR
This review will focus on the comparative properties of gabapentin and pregabalin, specifically the available evidence on their use in the treatment of primary anxiety disorders — GAD, social anxiety disorder, panic disorder, and obsessivecompulsive disorder. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 82 REFERENCES
Misuse and Abuse of Pregabalin and Gabapentin: Cause for Concern?
TLDR
Physicians considering prescribing gabapentinoids for neurological/psychiatric disorders should carefully evaluate a possible previous history of drug abuse, whilst being able to promptly identify signs of pregabalin/gabAPentin misuse and provide possible assistance in tapering off the medication. Expand
Profiles of pregabalin and gabapentin abuse by postmortem toxicology.
TLDR
All medico-legal death cases in Finland in which PRG or GBP was found in postmortem toxicology during 2010-2011 are investigated to estimate the proportion of all PRG- and GBP-related fatalities attributable to PRG andGBP abuse. Expand
Abuse of Gabapentin is Associated with Opioid Addiction
TLDR
A growing concern about gabapentin misuse was supported in this study: 26 percent of opiate addicted patients reported illegally obtaining, overusing, or malingering problems to obtain gabAPentin. Expand
Pregabalin Abuse amongst Opioid Substitution Treatment Patients.
TLDR
This study confirms that Pregabalin abuse is taking place amongst the addiction services population in Ireland and believes that misuse of this prescription drug is a serious emerging issue which should be monitored carefully. Expand
Misuse of the γ-aminobutyric acid analogues baclofen, gabapentin and pregabalin in the UK.
TLDR
The aim of this study was to determine the prevalence, frequency and sources of misuse of the GABA analogues (baclofen, gabapentin and pregabalin) in the UK, and to benchmark against existing national data provided by the 2011/2012 Crime Survey for England and Wales. Expand
Gabapentinoid Abuse in Order to Potentiate the Effect of Methadone: A Survey among Substance Misusers
Background/Aims: There is emerging evidence of gabapentin and pregabalin (gabapentinoid) abuse, particularly in the substance misuse population, and some suggestion of gabapentinoids being abusedExpand
Disproportionality Analysis for the Assessment of Abuse and Dependence Potential of Pregabalin in the French Pharmacovigilance Database
TLDR
The first cases of pregabalin-related abuse or dependence reported in France occurred later than in other European countries, since none had been described before 2010, underlines the limitations of spontaneous reporting system in the field of addictovigilance. Expand
Pregabalin abuse and dependence in Germany: results from a database query
TLDR
The aim of this study was to identify the number of cases of PRG abuse or dependence reported to the database of a German medical regulatory body and to obtain insights into further usage-specific parameters. Expand
Use of Pregabalin - A Nationwide Pharmacoepidemiological Drug Utilization Study with Focus on Abuse Potential.
TLDR
Male gender and prescription of antipsychotics and benzodiazepines were associated with increased risk of use of above the recommended dosage and use of pregabalin above recommended dosages was rare but abuse may occur in susceptible patients. Expand
Characterization Of Gabapentin Overdose Using A Poison Center Case Series
TLDR
In this cases series, gabapentin exposures caused no or minimal toxicity, and patients remained asymptomatic with reported effects of drowsiness and ataxia. Expand
...
1
2
3
4
5
...